Healthtech funding in H2 2017
European Healthtech startup funding raised during H2 2017.
In H2 2017, 153 European Healthtech companies closed 155 funding rounds and raised €1.7B in equity funding (excluding debt and grants), up 100.2% versus H2 2016. Switzerland led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.7B
+100.2% vs H2 2016 · excl. debt & grants
Funding rounds
155
-13.9% vs H2 2016
Companies
153
Top country
Switzerland
Rank among sectors
#3
11.6% of sector funding
Top-10 round share
69.3%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H2 2017 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €237M | 47 |
| Aug | €1.1B | 29 |
| Sep | €207M | 36 |
| Oct | €123M | 25 |
| Nov | €123M | 18 |
Top countries
by € raisedHealthtech — top countries by capital, H2 2017 — interactive chart.
Data table
| Healthtech — top countries by capital, H2 2017 | |
|---|---|
| Switzerland | €1.1B |
| France | €239M |
| UK | €172M |
| Israel | €110M |
| Germany | €59M |
| Sweden | €44M |
| Ireland | €17M |
| Finland | €15M |
Stage mix
by € raisedHealthtech — stage mix, H2 2017 — interactive chart.
Data table
| Healthtech — stage mix, H2 2017 | |
|---|---|
| Growth/Late | €938M |
| Other | €370M |
| Series A | €174M |
| Series B | €131M |
| Series C | €50M |
| Series D+ | €48M |
| Seed | €26M |
| Early VC | €4.2M |
| Grant | €1.6M |
Exits & M&A
9 Acquisition9 exits · €112M disclosed.
| VisionSense | Acquisition | Oct 2017 | €68M |
| iSalud | Acquisition | Sep 2017 | €30M |
| Vitalsana | Acquisition | Oct 2017 | €14M |
Top deals
largest disclosed rounds in H2 2017| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Growth/Late | Aug 2017 | €938M |
| Nouscom | Series B | Nov 2017 | €42M |
| Ada health | Series A | Oct 2017 | €40M |
| Nightstar | Series C | Jul 2017 | €39M |
| Sophia Genetics | Series D+ | Jul 2017 | €26M |
| NicOx | Other | Sep 2017 | €26M |
| Natural Cycles | Series B | Nov 2017 | €26M |
| MitrAssist | Other | Nov 2017 | €26M |
| GenSight Biologics | Other | Sep 2017 | €23M |
| Doctorlink | Other | Oct 2017 | €22M |
| Push Doctor | Series B | Aug 2017 | €22M |
| Ieso | Other | Sep 2017 | €20M |
| Eligo Bioscience | Series A | Sep 2017 | €17M |
| Sparingvision | Other | Jul 2017 | €16M |
| Bioserenity | Series A | Aug 2017 | €15M |
Top investors
most active in H2 2017, by deal count- High-Tech Gründerfonds (HTGF)6 deals
- Seventure Partners5 deals
- Bpifrance4 deals
- IDInvest Partners4 deals
- Accelerated Digital Ventures2 deals
- Atlantic Labs2 deals
- Draper Esprit2 deals
- EQT Ventures2 deals
- FRII2 deals
- Gefen Capital2 deals